Molecular basics of angiogenesis;Molekularne podstawy angiogenezy

Postepy Higieny i Medycyny Doswiadczalnej

Volumn 60, Issue , 2006, Pages 410-415

  Skóra, Jan ^a   Biegus, Jan ^b   Pupka, Artur ^a   Barć, Piotr ^a   Sikora, Julita ^c   Szyber, Piotr ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b 4 Wojskowy Szpital Kliniczny Z Polikliniką We Wrocławiu ^*  (Poland)

^c Katedra i Klinika Dermatologii   (Poland)

Author keywords

Angiogenesis; Endothelial progenitor cells; Extracellular matrix; VEGF (vascular endothelial growth factor)

Indexed keywords

CYTOKINE; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL; CYTOLOGY; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; NEOVASCULARIZATION (PATHOLOGY); PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; STEM CELL;

ANIMALS; CYTOKINES; ENDOTHELIAL CELLS; ENGLISH ABSTRACT; EXTRACELLULAR MATRIX; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; STEM CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33846051498     PISSN: 00325449     EISSN: 17322693     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Barańska P., Jerczyńska H., Pawłowska Z.: Czynnik wzrostu s̈ródbłonka naczyń-budowa i funkcja. Post. Biochem., 2005; 51: 12-21
2. Choksy S., Pockley A.G., Wajeh Y.E., Chan P.: VEGF and VEGF receptor expression in human chronic critical limb ischemia. Eur. J. Vasc. Endovasc. Surg., 2004; 28: 660-669
3. Conway E.M., Collen D., Carmeliet P.: Molecular mechanisms of blood vessel growth. Cardiovasc. Res. 2001; 49: 507-521
4. Coultas L., Chawengsaksophak K., Rossant J.: Endothelial cells and VEGF in vascular development. Nature, 2005; 438: 937-945
5. Davis G.E., Senger D.R.: Endothelial extracellular matrix: biosynthesis, remodeling, and functions during vascular morphogenesis and neovessel stabilization. Circ. Res., 2005; 97:1093-1107
6. Eliceiri B.P., Cheresh D.A.: The role of av integrins during angiogenesis: insights into potential mechanisms of action and clinical development. J. Clin. Invest., 1999; 103: 1227-1230
7. Epstein S.E., Fuchs S., Zhou Y.F., Baffour R., Kornowski R.: Therapeutic interventions for enhancing collateral development by administration of growth factors: basic principles, early results and potential hazards. Cardiovasc. Res., 2001; 49: 532-542
8. Epstein S.E., Kornowski R., Fuchs S., Dvorak H.F.: Angiogenesis therapy amidst the hype, the neglected potential for serious side effects. Circulation, 2001; 104: 115-119
9. Fam N.P., Verma S., Kutryk M., Stewart D.J.: Clinician guide to angiogenesis. Circulation, 2003; 108: 2613-2618
10. Felmeden D.C., Blann A.D., Lip G.Y.: Angiogenesis: basic pathophysiology and implications for disease. Eur. Heart J., 2003; 24: 586-603
11. Galis Z.S., Khatri J.J.: Matrix metalloproteinases in vascular remodeling and atherogenesis the good, the bad, and the ugly. Circ. Res., 2002; 90: 251-262
12. Grafte-Faure S., Leveque C., Ketata E., Jean P., Vasse M., Soria C., Vannier J.P.: Recruitment of primitive peripheral blood cells: synergism of interleukin12 with interleukin 6 and stromal cell-derived factor-1. Cytokine, 2000; 12: 1-7
13. Grosjean J., Kiriakidis S., Reilly K., Feldmann M., Paleolog E.: Vascular endothelial growth factor signalling in endothelial cell survival: A role for NFkappaB. Biochem. Biophys. Res. Commun., 2006; 340: 984-994
14. Hattori K., Heissig B., Tashiro K., Honjo T., Tateno M., Shieh J.H., Hackett N.R., Quitoriano M.S., Crystal R.G., Rafii S., Moore M.A.: Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells. Blood, 2001; 97: 3354-3360
15. Heil M., Schaper W.: Influence of mechanical, cellular, and molecular factors on collateral artery growth (arteriogenesis). Circ. Res., 2004; 95: 449-458
16. Hill J.M., Zalos G., Halcox J.P., Schenke W.H., Waclawiw M.A., Quyyumi A.A., Finkel T.: Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N. Engl. J. Med., 2003; 348: 593-600
17. Hojo Y., Ikeda U., Zhu Y., Okada M., Ueno S., Arakawa H., Fujikawa H., Katsuki T., Shimada K.: Expression of vascular endothelial growth factor in patients with acute myocardial infarction. J. Am. Coll. Cardiol., 2000; 35: 968-973
18. Hristov M., Erl W., Weber P.C.: Endothelial progenitor cells: mobilization, differentiation, and homing. Arterioscler. Thromb. Vasc. Biol., 2003; 23: 1185-1189
19. Iijima K., Yoshikawa N., Connolly D.T., Nakamura H.: Human mesangial cells and peripheral blood mononuclear cells produce vascular permeability factor. Kidney Int., 1993; 44: 959-996
20. Ingber D.E. Mechanical signaling and the cellular response to extracellular matrix in angiogenesis and cardiovascular physiology. Circ. Res., 2002; 91: 877-887
21. Jackson C.: Matrix metalloproteinases and angiogenesis. Curr. Opin. Nephrol. Hypertens., 2002; 11: 295-299
22. Jackson K.A., Majka S.M., Wang H., Pocius J., Hartley C.J., Majesky M.W., Entman M.L., Michael L.H., Hirschi K.K., Goodell M.A.: Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J. Clin. Invest., 2001; 107: 1395-1402
23. Lataillade J.J., Clay D., Dupuy C., Rigal S., Jasmin C., Bourin P., Le Bousse-Kerdiles M.C.: Chemokine SDF-1 enhances circulating CD34(+) cell proliferation in synergy with cytokines: possible role in progenitor survival. Blood, 2000; 95: 756-768
24. Namieciñska M., Marciniak K.,. Nowak J.Z.: VEGF jako czynnik angiogenny, neurotroficzny i neuroprotekcyjny. Post. Hig. Med. Dosw., 2005; 59: 573-583
25. Peichev M., Naiyer A.J., Pereira D., Zhu Z., Lane W.J., Williams M., Oz M.C., Hicklin D.J., Witte L., Moore M.A., Rafii S.: Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood, 2000; 95: 952-958
26. Pepper M.S.: Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. Arterioscler. Thromb. Vasc. Biol., 2001; 21: 1104-1117
27. Schober A., Knarren S., Lietz M., Lin E.A., Weber C.: Crucial role of stromal cell-derived factor-1 in neointima formation after vascular injury in apolipoprotein E-deficient mice. Circulation, 2003; 108: 2491-2497
28. Schwarz E.R., Meven D.A., Sulemanjee N.Z., Kersting P.H., Tussing T., Skobel E.C., Hanrath P., Uretsky B.F.: Monocyte chemoattractant protein 1-induced monocyte infiltration produces angiogenesis but not arteriogenesis in chronically infarcted myocardium. J. Cardiovasc. Pharmacol. Ther., 2004; 9: 279-289
29. Senger D.R., Connolly D.T., Van de Water L., Feder J., Dvorak H.F.: Purification and NH2-terminal amino acid sequence of Guinea pig tumor-secreted vascular permeability factor. Cancer Res., 1990; 50: 1774-1778
30. Shintani S., Murohara T., Ikeda H., Ueno T., Honma T., Katoh A., Sasaki K., Shimada T., Oike Y., Imaizumi T.: Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation, 2001; 103: 2776-2779
31. Tabibiazar R., Rockson S.G.: Angiogenesis and the ischaemic heart. Eur. Heart J., 2001; 22: 903-918
32. Takahashi T., Kalka C., Masuda H., Chen D., Silver M., Kearney M., Magner M., Isner J.M., Asahara T.: Ischemia-and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat. Med., 1999; 5: 434-438
33. Teichert-Kuliszewska K., Maisonpierre P.C., Jones N., Campbell A.I., Master Z., Bendeck M.P., Alitalo K., Dumont D.J., Yancopoulos G.D., Stewart D.J.: Biological action of angiopoietin-2 in a fibrin matrix model of angiogenesis is associated with activation of Tie2. Cardiovasc. Res., 2001; 49: 659-670
34. The Medical Biochemistry Page http://web.indstate.edu/thcme/mwking/extracellularmatrix.html (03.10.2005)
35. Thurston G., Rudge J.S., Ioffe E., Zhou H., Ross L., Croll S.D., Glazer N., Holash J., McDonald D.M., Yancopoulos G.D.: Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat. Med., 2000; 6: 460-463
36. Tischer E., Gospodarowicz D., Mitchell R., Silva M., Schilling J., Lau K., Crisp T., Fid-des J.C., Abraham J.A.: Vascular endothelial growth factor: A new member of the platelet-derived growth factor gene family. Biochem. Biophys. Res. Commun., 1989; 165: 1198-1206
37. Vasa M., Fichtlscherer S., Adler K., Aicher A., Martin H., Zeiher A.M., Dimmeler S.: Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation, 2001; 103: 2885-2890
38. Vasa M., Fichtlscherer S., Aicher A., Adler K., Urbich C., Martin H., Zeiher A.M., Dimmeler S.: Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ. Res., 2001; 89: E1-E7
39. Visse R., Nagase H.: Matrix metalloproteinases and tissue inhibitors of metalloproteinases structure, function, and biochemistry. Circ. Res., 2003; 92: 827-839
40. Yamaguchi J., Kusano K.F., Masuo O., Kawamoto A., Silver M., Murasawa S., Bosch-Marce M., Masuda H., Losordo D.W., Isner J.M., Asahara T.: Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascula-rization. Circulation, 2003; 107: 1322-1328